Sean Brynjelsen

Chief Executive Officer at ETON PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 2024-04-29

52 year

Health Technology

Consumer Services

Sean Brynjelsen active positions

Companies	Position	Start	End
ETON PHARMACEUTICALS, INC.	Director/Board Member	2017-05-31	-
	Chief Executive Officer	2017-05-31	-
	President	2017-05-31	-

Companies	Position	Start	End
SAGENT PHARMACEUTICALS INC	Corporate Officer/Principal	2016-03-22	2017-05-31
AKORN, INC.	Chief Tech/Sci/R&D Officer	2010-06-17	2014-02-06
AKORN, INC.	Corporate Officer/Principal	2014-02-06	2016-02-29

University of Notre Dame	Masters Business Admin
University of Illinois	Graduate Degree

International

United States

Operational

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Masters Business Admin	1

Sectoral

Health Technology	4
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
ETON PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Akorn, Inc. Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.	Health Technology
Sagent Pharmaceuticals, Inc. Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.	Health Technology

Private companies

Health Technology